These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2823752)

  • 21. Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis.
    Kleefeld F; Uruha A; Schänzer A; Nishimura A; Roos A; Schneider U; Goebel HH; Schuelke M; Hahn K; Preusse C; Stenzel W
    Neurology; 2022 Nov; 99(20):e2212-e2222. PubMed ID: 36195449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical forms of inclusion body myositis: 12 cases].
    Serratrice G; Pellissier JF; Pouget J; Figarella-Branger D
    Rev Neurol (Paris); 1989; 145(11):781-8. PubMed ID: 2556772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inclusion body myositis.
    Chou SM
    Baillieres Clin Neurol; 1993 Nov; 2(3):557-77. PubMed ID: 8156143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inclusion body myositis: clinical and histopathological features of 36 patients.
    Beyenburg S; Zierz S; Jerusalem F
    Clin Investig; 1993 May; 71(5):351-61. PubMed ID: 8389626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of macrophages, activated cells and T cell subsets in inflammatory myopathies using monoclonal antibodies.
    Giorno R; Ringel SP
    Pathol Immunopathol Res; 1986; 5(6):491-9. PubMed ID: 3112759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
    Choi YC; Dalakas MC
    Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory myopathies with mitochondrial pathology and protein aggregates.
    Temiz P; Weihl CC; Pestronk A
    J Neurol Sci; 2009 Mar; 278(1-2):25-9. PubMed ID: 19101700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies.
    Engel AG; Arahata K
    Hum Pathol; 1986 Jul; 17(7):704-21. PubMed ID: 3459704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory muscle diseases.
    Mastaglia FL
    Neurol India; 2008; 56(3):263-70. PubMed ID: 18974552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
    Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
    Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of inclusion body myositis (IBM) associated with lipid-storage vacuoles].
    Hida C; Endo K; Hirayama K; Awano H; Yamamoto T
    Rinsho Shinkeigaku; 1995 Apr; 35(4):396-402. PubMed ID: 7614766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative histopathology of the inflammatory myopathies.
    Ringel SP; Carry MR; Aguilera AJ; Starcevich JM
    Arch Neurol; 1986 Oct; 43(10):1004-9. PubMed ID: 3753261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A
    Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory and toxic myopathies.
    Dalakas MC
    Curr Opin Neurol Neurosurg; 1992 Oct; 5(5):645-54. PubMed ID: 1327303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
    J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inclusion body myositis--a review.
    Vogel H
    Adv Anat Pathol; 1998 May; 5(3):164-9. PubMed ID: 9868522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Idiopathic inflammatory myopathies].
    Figarella-Branger D; Lacroix C; Coquet M; Gherardi R; Pellissier JF
    Ann Pathol; 2001 Jun; 21(3):279-84. PubMed ID: 11468572
    [No Abstract]   [Full Text] [Related]  

  • 38. Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product.
    Figarella-Branger D; Pellissier JF; Bianco N; Devictor B; Toga M
    Acta Neuropathol; 1990; 79(5):528-36. PubMed ID: 2158202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathies.
    Dalakas MC
    Clin Neuropharmacol; 1992 Oct; 15(5):327-51. PubMed ID: 1423335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions.
    Molnar M; Schröder JM
    Acta Neuropathol; 1998 Jul; 96(1):41-51. PubMed ID: 9678512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.